Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease

13 Feb 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Neurological disorders and treatments
Share to Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 39952239
DOI: 10.1016/j.stem.2025.01.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s diseasePMID 39952239Read ↗

Clinical trials test the safety of stem-cell therapy for Parkinson’s diseaseSemantic proximity Read ↗

Stem cell therapies for Parkinson’s diseaseSemantic proximity Read ↗

Developing Stem Cell Therapies for Parkinson’s Disease: Waiting Until the Time Is RightSemantic proximity Read ↗

Stem cell therapy for Parkinson’s disease: safety and modelingSemantic proximity Read ↗

Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and LimitationsSemantic proximity Read ↗

‘Reprogrammed’ stem cells implanted into patient with Parkinson’s diseaseSemantic proximity Read ↗

Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant PhenotypesSemantic proximity Read ↗

Autologous Versus Allogeneic iPSC-Derived Dopaminergic Neuron Therapy for Parkinson’s Disease: Molecular Mechanisms and Translational Trade-OffsSemantic proximity Read ↗

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challengesSemantic proximity Read ↗

Towards stem cell based therapies for Parkinson's diseaseSemantic proximity Read ↗

Advancing Parkinson’s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cellsSemantic proximity Read ↗

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be hereSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.